Summary
Aware reported fourth quarter 2020 revenue of $3.4 million, up 39.8% from the prior-year quarter. Full-year revenue was $11.3 million, down 7.3% from 2019. The quarter's growth came from higher perpetual license and subscription revenues, according to the press release. Subscription revenue quintupled, and the pipeline nearly doubled. Operating loss was $1.9 million in the quarter. Net loss was $1.6 million in the quarter and $7.6 million for the full year. Diluted EPS was negative $0.35 for the full year, up 10.3% from the prior year. Operating margin was negative 54.2% in the quarter, up 18.4 percentage points from the prior-year quarter, but full-year operating margin was negative 83.3%, down 49.1 percentage points. The company said the quarter marked its second consecutive quarter of significant revenue growth.
Operationally, Aware launched AwareABIS, a modular Automated Biometric Identification System designed for 1-30 million identities. The company said the new product supports large-scale, multi-modal biometric identification and deduplication. It became one of only two US companies to satisfy level 1 and level 2 compliance with the US Government's Personal Identity Verification requirements after completing NIST MINEX III testing. Aware also unveiled Knomi 2.13, an updated mobile biometric software product that matches both masked and unmasked images without sacrificing speed or usability. The company acquired the Maxar Technologies AFIX product suite to add turnkey face and fingerprint matching and forensic analysis for small and medium law enforcement and government agencies. The CEO joined the board of the International Biometrics + Identity Association. Management described 2020 as a period of transformation, with offerings readied for subscription and consumption-based models and a reinvigorated commercial side. The company said it nearly doubled the pipeline, quintupled high-margin recurring subscription revenue, and completed its first acquisition.
Total costs and expenses increased while revenue declined for the full year. The full-year operating loss was $9.4 million, compared with a loss in 2019. The company said the higher operating loss was primarily due to lower revenue and higher operating costs, including investments in sales and engineering resources and non-recurring expenses in the first half of 2020. The full-year revenue decrease was primarily due to lower services revenue related to a multiyear international project signed with a systems integrator in the second quarter of 2018, partially offset by higher software subscription revenue. Software license revenue increased as a percentage of total revenue, while services revenue declined. Operating cash flow was negative $5.3 million for the full year, down 79.1% from 2019. Capital expenditures were $0.02 million in the quarter, down 39.4% from the prior-year quarter, and $0.48 million for the full year, up 336.0%. Deferred revenue rose 38.6% to $3.9 million, and remaining performance obligations rose 71.4% to $2.4 million. Those balances point to some backlog and recurring revenue momentum. The company said it has no material commitments for capital expenditures.
Management did not provide specific revenue or earnings guidance for the next quarter or the full fiscal year. It framed 2021 as a year to capitalize on growth catalysts, including the new ABIS product and the AFIX acquisition, and said it is evaluating accretive opportunities and partnerships. Risks include significant government customer concentration, intense competition, rapid technological change, cybersecurity threats, reliance on third-party software, and the ongoing COVID-19 pandemic. Management believes the pandemic will likely have an adverse impact on revenue over the next several quarters. The company also said gross margins on services will continue to fluctuate based on the nature, complexity, and pricing of future projects. Cash and cash equivalents were lower than a year earlier, but management believes cash will be sufficient to fund operations for at least the next twelve months from the filing date of the annual report. Management said it took cost-containment measures for the year to come and believes its engineering organization was adequately staffed as of December 31, 2020. The company said it intends to introduce new products to offer more complete biometrics solutions and may purchase or license technologies from third parties if it cannot develop them internally.
Forecast
No forward guidance in this quarter's filings.
Reported figures
GAAP, from SEC filings| Metric | Q4 FY2020 | Q3 FY2020 | QoQ | Q4 FY2019 | YoY |
|---|---|---|---|---|---|
| Revenue | $3.4M | $2.5M | +38.5% | $2.5M | +39.8% |
| Gross profit | $3.1M | $2.3M | +33.3% | — | — |
| Gross margin | 90.5% | 94.0% | -3.5 pp | — | — |
| Research & development | $2.1M | $2.3M | -11.4% | $2.0M | +3.0% |
| Sales & marketing | $1.6M | $1.3M | +25.6% | $945.0K | +73.5% |
| General & administrative | $1.2M | $1.2M | +3.5% | $1.1M | +16.4% |
| Total operating expenses | $5.3M | $5.0M | +5.8% | $4.2M | +26.4% |
| Operating income (loss) | -$1.9M | -$2.5M | +26.3% | -$1.7M | -7.3% |
| Operating margin | -54.2% | -101.9% | +47.7 pp | -70.6% | +16.4 pp |
| Net income (loss) | -$1.6M | -$1.8M | +7.9% | -$7.5M | +78.1% |
| Net margin | -47.8% | -71.8% | +24.1 pp | -305.3% | +257.5 pp |
| Diluted EPS | -$0.08 | -$0.08 | ±$0.00 | -$0.35 | +$0.27 |
Risks
The company says COVID-19 prevented face-to-face customer meetings, in-person software demonstrations, trade shows and strategic partner meetings, adversely impacted 2020 operating and financial results and will likely have an adverse impact over the next several quarters. FY2020 revenue was $11.31M, down 7.3% from FY2019, and operating loss widened to $9.42M from $4.18M.
Individual orders can represent a meaningful percentage of quarterly revenue and timing is difficult to predict; failure to close, deferral or cancellation can cause revenue and net income shortfalls. FY2020 revenue fell 7.3% to $11.31M while operating costs are largely fixed, and FY2020 operating loss widened 125.6% to $9.42M.
A significant portion of revenue is derived directly or indirectly from federal, international, state and local government customers, exposing results to changes in government contracting policies, funding priorities, budget constraints, appropriations delays and payment delays.
MD&A reports services revenue decreased 64% from $2.3M in 2019 to $0.8M in 2020, and gross margins on services decreased from 46% in 2019 to 4% in 2020, largely due to lower services on a large systems integrator project. This mix shift contributed to the FY2020 operating loss widening to $9.42M.
G&A expense increased 51% from $3.6M in 2019 to $5.4M in 2020, including $0.7M of severance and transition expense and costs from turnover of over 50% of administrative personnel. The risk factor notes key employee departures could cause difficulty hiring successors and loss of productivity.
The company acquired AFIX in November 2020 and used $2.4M of investing cash for the acquisition. Risk factors warn integration is costly and time-consuming, benefits may not exceed costs, and future acquisition consideration could dilute shareholders.
The biometrics market faces intense competition from established providers such as Idemia, Thales, NEC, FaceTec, Dermalog and Innovatrics, and low-cost foreign competitors may sell at significantly reduced prices. Many competitors have substantially greater financial, marketing and research resources.
Privacy and data protection rules including GDPR, CCPA, Illinois Biometric Privacy Act, Texas biometric statute, Washington H.B. 1493 and Brazil's LGPD may impose compliance costs and affect use of biometric products and services.
A significant portion of revenue comes from third party systems integrators and OEM partners, and the company does not directly control their sales efforts, government award success, technical capabilities or financial viability. Loss of a major partner could materially harm results.
A significant commercial market for biometrics technology may not develop, and adoption has been limited and slow. Even if demand grows, there is no assurance Aware's biometrics products will achieve market acceptance.
The company expects a growing percentage of revenue from cloud-based services, so widespread acceptance of the cloud model is critical. Resistance to accessing software as a service through a third party could negatively affect demand.
Cash used by operating activities was $5.3M in 2020, down 79.1% from $2.9M in 2019, driven primarily by a $7.6M net loss. Although cash and cash equivalents were $38.6M at December 31, 2020, continued operating cash use could pressure liquidity.
Summary, forecast, risks and KPIs are extracted from AWARE INC /MA/'s SEC filings for Q4 FY2020 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Oct 21, 2026.